Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-20 · accession 0001724521-23-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-22 | 2023-12-20 | RCUS | Azoy Alexander | CAO | D - Sale to Iss | $18.21 | -68 | 10.2K | -0.7% | -$1,238 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-20 | D | D | 68 | $18.21 | 10,220 | D | — | — | (F1) The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 30, 2023. |